Sclerostin is an independent risk factor for all-cause mortality in kidney transplant recipients

Sclerostin is a hormone contributing to the bone-vascular wall cross talk and has been implicated in cardiovascular events and mortality in patients with chronic kidney disease (CKD). We analyzed the relationship between sclerostin and mortality in renal transplant recipients.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zeng, Shufei (VerfasserIn) , Slowinski, Torsten (VerfasserIn) , Pommer, Wolfgang (VerfasserIn) , Hasan, Ahmed A. (VerfasserIn) , Gaballa, Mohamed Mahmoud Salem Ahmed (VerfasserIn) , Lu, YongPing (VerfasserIn) , Krämer, Bernhard (VerfasserIn) , Hocher, Berthold (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 August 2020
In: Clinical and experimental nephrology
Year: 2020, Jahrgang: 24, Heft: 12, Pages: 1177-1183
ISSN:1437-7799
DOI:10.1007/s10157-020-01956-y
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10157-020-01956-y
Volltext
Verfasserangaben:Shufei Zeng, Torsten Slowinski, Wolfgang Pommer, Ahmed A. Hasan, Mohamed M. S. Gaballa, Yongping Lu, Bernhard K. Krämer, Berthold Hocher
Beschreibung
Zusammenfassung:Sclerostin is a hormone contributing to the bone-vascular wall cross talk and has been implicated in cardiovascular events and mortality in patients with chronic kidney disease (CKD). We analyzed the relationship between sclerostin and mortality in renal transplant recipients.
Beschreibung:Gesehen am 12.08.2021
Beschreibung:Online Resource
ISSN:1437-7799
DOI:10.1007/s10157-020-01956-y